The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Last week, the FDA approved two new warnings on the labeling for two skin care drugs, Elidel and Protopic. Although a causal link between these two topical drugs and certain cancers has not yet been established, patients receiving these drugs have reported a higher incidence of cancers, namely skin cancer and lymphoma.

Patients taking these drugs are encouraged to consult with their doctor to determine the proper and safe use of Elidel and Protopic.

Comments are closed.

Of Interest